Published in MAGMA on March 13, 2013
Advances in diffusion-weighted imaging. Radiol Clin North Am (2015) 0.89
Diffusion-weighted magnetic resonance imaging in cancer: Reported apparent diffusion coefficients, in-vitro and in-vivo reproducibility. World J Radiol (2016) 0.84
Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients. Clin Nucl Med (2016) 0.82
The Accuracy of ADC Measurements in Liver Is Improved by a Tailored and Computationally Efficient Local-Rigid Registration Algorithm. PLoS One (2015) 0.75
Apparent Diffusion Coefficient Quantification in Determining the Histological Diagnosis of Malignant Liver Lesions. J Cancer (2016) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology (2004) 3.59
Diffusion-weighted MR imaging of the liver. Radiology (2010) 3.50
Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology (2003) 2.75
Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology (2008) 2.34
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol (2007) 2.07
Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol (1999) 2.00
Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed (1996) 1.96
Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology (2008) 1.73
High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology (2011) 1.64
Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology (1997) 1.62
Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol (2007) 1.60
Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging (2008) 1.44
Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology (2008) 1.41
Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values. AJR Am J Roentgenol (2009) 1.39
Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology (2010) 1.36
Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging (2011) 1.34
Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol (2006) 1.32
Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology (2012) 1.25
Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol (2009) 1.18
Diffusion weighted imaging in the liver. World J Gastroenterol (2010) 1.15
The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci (2006) 1.08
Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology (2010) 1.07
Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging. Eur J Radiol (2009) 1.02
Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed (2006) 1.01
Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWI techniques and calculation methods. J Magn Reson Imaging (2012) 1.00
MR-diffusion weighted imaging of healthy liver parenchyma: repeatability and reproducibility of apparent diffusion coefficient measurement. J Magn Reson Imaging (2010) 0.97
Respiratory bellows revisited for motion compensation: preliminary experience for cardiovascular MR. Magn Reson Med (2010) 0.95
Hepatic pseudo-anisotropy: a specific artifact in hepatic diffusion-weighted images obtained with respiratory triggering. MAGMA (2007) 0.94
Diffusion-weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): a feasibility study. J Magn Reson Imaging (2009) 0.85
Comparison of breathhold, navigator-triggered, and free-breathing diffusion-weighted MRI for focal hepatic lesions. J Magn Reson Imaging (2012) 0.80
Caval blood flow during supine exercise in normal and Fontan patients. Ann Thorac Surg (2008) 0.80
Evaluation of noncirrhotic hepatic parenchyma with and without significant portal vein stenosis using diffusion-weighted echo-planar MR on the basis of multiple-perfusion-components theory. Magn Reson Imaging (2010) 0.77
[An experimental study on rabbit liver by 3.0 Tesla magnetic resonance diffusion-weighted imaging]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2012) 0.75
In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J (2004) 3.38
Defining adductor canal block. Reg Anesth Pain Med (2014) 2.48
Redefining the adductor canal block. Reg Anesth Pain Med (2014) 1.61
Three-dimensional, isotropic MRI: a unified approach to quantification and visualization in congenital heart disease. Int J Cardiovasc Imaging (2005) 1.53
From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol (2010) 1.49
MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2008) 1.33
Operator-independent isotropic three-dimensional magnetic resonance imaging for morphology in congenital heart disease: a validation study. Circulation (2004) 1.22
Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol (2013) 1.01
Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol (2011) 0.96
Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol (2010) 0.94
Three-dimensional phase contrast velocity mapping acquisition improves wall shear stress estimation in vivo. Magn Reson Imaging (2004) 0.94
Aortic dimensions in girls and young women with turner syndrome: a magnetic resonance imaging study. Pediatr Cardiol (2010) 0.92
Two-phase active contour method for semiautomatic segmentation of the heart and blood vessels from MRI images for 3D visualization. Comput Med Imaging Graph (2001) 0.89
Impact of luminal density on plaque classification by CT coronary angiography. Int J Cardiovasc Imaging (2010) 0.88
Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging. Cardiol Young (2010) 0.86
Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer. Acta Oncol (2010) 0.85
Visualization of morphological details in congenitally malformed hearts: virtual three-dimensional reconstruction from magnetic resonance imaging. Cardiol Young (2003) 0.84
Blood flow measured by magnetic resonance imaging at rest and exercise after surgical bypass of aortic arch obstruction. Eur J Cardiothorac Surg (2009) 0.82
Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1. Invest Radiol (2014) 0.81
Intensity profile based measurement of prostate gold markers influence on 1.5 and 3T diffusion-weighted MR images. Acta Oncol (2011) 0.80
Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer. Acta Oncol (2014) 0.79
Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status. Clin Endocrinol (Oxf) (2007) 0.79
Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer. Acta Oncol (2013) 0.78
Images in cardiovascular medicine. Total cavo-pulmonary connection: a virtual 3-dimensional fly-through. Circulation (2002) 0.77
[Ovarian metastases from ventricular cancer diagnosed using diffusion-weighted 3T magnetic resonance imaging]. Ugeskr Laeger (2011) 0.76
Imaging atherosclerotic plaques by cardiac computed tomography in vitro: impact of contrast type and acquisition protocol. Invest Radiol (2011) 0.75
Hemodynamic effects of closure of residual arteriovenous fistulae during in situ graft procedures. Vascular (2010) 0.75
[In Process Citation]. Ugeskr Laeger (2014) 0.75
Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma. Invest Radiol (2017) 0.75